Skip to main content
. 2023 Feb 22;8(4):e166485. doi: 10.1172/jci.insight.166485

Table 1. Measurements of pharmaceutical active or surrogate pharmaceutical metabolite in each treatment group.

graphic file with name jciinsight-8-166485-g129.jpg